Por: MarketWatch Business September 18, 2023
The transaction in question occurred just ahead of Lyft Inc.’s March 2019 initial public offering, in which Icahn sought to unload 7.7 million shares — or roughly a 2.6% stake in the company, the SEC said. Initially, Lyft’s board rejected a big investor’s effort to sell a stake in the company, citing possible insider-trading issues due to the investor’s knowledge of details of the IPO, the SEC said. Prior SEC filings show that the... + full article
MarketWatch USA Business September 18, 2023
The transaction in question occurred just ahead of Lyft Inc.’s March 2019 initial public offering, in which Icahn sought to unload 7.7 million shares — or roughly a 2.6% stake in the company, the SEC said. Initially, Lyft’s board rejected a big investor’s effort to sell... + más
Icahn investment arm’s stock slides anew and is close to its 52-week low | MarketWatch
Lyft fined for board member not disclosing role in pre-IPO Icahn-Soros stock sale | MarketWatch
MarketWatch USA Business August 22, 2023
A Tuesday highlighted the fallout from the Hindenburg report for billionaire activist Carl Icahn and his publicly traded investment arm . The Nate Anderson-backed Hindenburg had accused Icahn Enterprises of overstating values and paying a dividend it could not afford. The stock... + más
Icahn Enterprises continues to tumble following Hindenburg short report, Bill Ackman's responses | ABC News
Icahn Enterprises continues to tumble following Hindenburg short report, Bill Ackman's responses | Associated Press
MarketWatch USA Business May 25, 2023
Illumina is holding its annual meeting at 1 p.m. Eastern time, at which the results of the proxy vote will be announced. The meeting will be held virtually, and is only open to shareholders. The stakes are high for Icahn, who needs a win. The Wall Street lion is facing an from a... + más
Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal | CNBC
Illumina ordered by FTC to unwind $7b Grail deal from 2021 | The Boston Globe
Associated Press USA Business May 25, 2023
WASHINGTON (AP) — The business empire of corporate raider and activist investor continues to tumble amid the fallout following a recent report from short-selling firm Hindenburg Research — and losses are accelerating as a longtime rival echoes the firm’s allegations.In the... + más
Activist investor Icahn becomes target of short seller | The Boston Globe
ABC News USA Business May 25, 2023
WASHINGTON -- The business empire of corporate raider and activist investor Carl Icahn continues to tumble amid the fallout following a recent report from short-selling firm Hindenburg Research — and losses are accelerating as a longtime rival echoes the firm's... + más
New York Post USA Business May 02, 2023
Billionaire corporate raider Carl Icahn’s hedge fund has allegedly created a “Ponzi-like economic structure” that has falsely inflated the value of his investments, according to bombshell allegations from a prominent short-seller on Tuesday. Hindenburg Research — whose... + más
Activist investor Carl Icahn's wealth plunged by $10 billion after a short-seller accused his company of running a 'Ponzi-like' structure | Business Insider
CNBC USA Health March 21, 2023
In this articleCarl IcahnAdam Jeffery CNBC Biotech company pushed back Monday against Carl Icahn's proxy fight over the company's acquisition of cancer test developer Grail, saying the activist investor's board nominees do not add value. The San Diego-based DNA... + más
Carl Icahn claims Illumina directors got extra insurance to close 'disastrous' $7.1 billion Grail deal | CNBC
Icahn proposes three candidates for Illumina’s board — Here’s what could be next in the battle | CNBC
About iurex | Privacy Policy | Disclaimer |